15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 97.0% per year over the past 5 years.
Financial health
Total debt has grown slower than revenue (3.0% vs 97.0% per year).
Operating income covered interest expense -149.5× in the latest year, down from -3.1× 5 years ago.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$31M
-$209M
0.0%
-550.3%
—
—
$205M
2024
$10M
-$131M
0.0%
-1149.6%
-$105M
$41M
$89M
2023
—
-$87M
—
—
—
$40M
$78M
2022
$3M
-$74M
0.0%
-2809.6%
—
$25M
$75M
2021
$2M
-$71M
0.0%
-2991.2%
-$54M
—
$21M
2020
—
-$68M
—
—
-$34M
—
$68M
2019
—
-$149M
—
—
-$139M
$35M
$44M
2018
—
-$72M
—
—
-$76M
$25M
$130M
2017
—
-$68M
—
—
—
$15M
$82M
2016
—
-$36M
—
—
-$30M
—
$32M
2015
—
-$58M
—
—
-$46M
—
$25M
2014
—
-$53M
—
—
—
—
$34M
2014
—
-$101M
—
—
—
—
$13M
2013
—
-$41M
—
—
—
—
$19M
2013
—
-$76M
—
—
—
—
$23M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$19M
-$37M
0.0%
-240.5%
—
—
$166M
Dec '25
$18M
-$33M
0.0%
-236.5%
—
—
$205M
Sep '25
$11M
-$99M
0.0%
-362.2%
—
—
$138M
Jun '25
$2M
-$26M
0.0%
-2047.9%
—
—
$164M
Mar '25
—
-$52M
—
—
—
—
$118M
Dec '24
$0
-$65M
—
—
-$25M
$41M
$89M
Sep '24
$0
-$24M
—
—
-$24M
$31M
$113M
Jun '24
$10M
-$8M
0.0%
-182.8%
-$28M
$35M
$83M
Mar '24
—
-$34M
—
—
-$28M
$40M
$81M
Dec '23
—
-$27M
—
—
—
$40M
$78M
Sep '23
—
-$20M
—
—
—
$40M
$95M
Jun '23
—
-$24M
—
—
—
$40M
$183M
Mar '23
—
-$16M
—
—
—
$40M
$97M
Dec '22
—
-$17M
—
—
—
$25M
$75M
Sep '22
—
-$18M
—
—
—
$24M
$78M
Jun '22
—
-$22M
—
—
—
$24M
$64M
Mar '22
—
-$17M
—
—
—
$24M
$47M
Dec '21
—
-$16M
—
—
-$10M
—
$21M
Sep '21
—
-$23M
—
—
-$11M
—
$24M
Jun '21
—
-$17M
—
—
-$13M
—
$25M
Valuation over time
How the market has priced VSTM against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has fallen from 14.0× (Mar '23) to 9.8× (Jun '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is VSTM growing its revenue and profit?
Over the past 5 years, Verastem, Inc.'s revenue has grown 97.0% per year. These are computed facts, not advice.
How much debt does VSTM have?
As of FY2025, Verastem, Inc. reported — of total debt against $205M of cash; operating income covered interest expense -149.5×.
What is VSTM's profit margin?
In FY2025, gross margin was —, operating margin -550.3%, and net margin -677.6%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.